Latest medicines approvals announced in Scotland and Wales

Latest medicines approvals announced in Scotland and Wales

June 22 2016 The All Wales Medicines Strategy Group has announced two new recommendations for...

Which? challenges dietary supplements claims around reducing dementia risk

Which? challenges dietary supplements claims around reducing dementia risk

June 20 2016 Consumers’ association Which? has challenged dietary supplement products which...

High dose loperamide linked with serious heart problems

High dose loperamide linked with serious heart problems

June 20 2016 A warning advising of a risk of severe cardiac problems associated with people...

CAM users less likely to start chemotherapy for breast cancer

CAM users less likely to start chemotherapy for breast cancer

May 18 2016 Women with breast cancer are less likely to start chemotherapy when using certain...

VMS may need to include iron and folic acid to help reduce some birth risks

VMS may need to include iron and folic acid to help reduce some birth risks

May 11 2016 Vitamin and mineral supplements (VMS) taken before a woman becomes pregnant or during...

  • Latest medicines approvals announced in Scotland and Wales

    Latest medicines approvals announced in Scotland and Wales

    Wednesday, 22 June 2016 14:31
  • Which? challenges dietary supplements claims around reducing dementia risk

    Which? challenges dietary supplements claims around reducing dementia risk

    Tuesday, 21 June 2016 13:23
  • High dose loperamide linked with serious heart problems

    High dose loperamide linked with serious heart problems

    Tuesday, 21 June 2016 11:45
  • CAM users less likely to start chemotherapy for breast cancer

    CAM users less likely to start chemotherapy for breast cancer

    Wednesday, 18 May 2016 14:50
  • VMS may need to include iron and folic acid to help reduce some birth risks

    VMS may need to include iron and folic acid to help reduce some birth risks

    Wednesday, 11 May 2016 13:46

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

NanoReproAG logo450

NanoRepro AG is an innovative leader in development, manufacturing and distribution of CE-certified rapid diagnostic tests (self-tests) and food supplements for both, home and professional use, in the domestic and international markets. Since October 2008, NanoRepro has been publicly listed with its headquarters located in Marburg, Germany.

Our goal is to provide accuracy in self-diagnostics for rapid disease detection.

Self-diagnostics is a fast growing market shaped by the ever-increasing health conscious of the population and healthcare spending. Our rapid diagnostic tests offer significant advantages over all available competitive products due to our flexibility in product design, in-depth market understanding and best practices of just-in-time manufacturing. Our most important success factor is continuous optimization of manufacturing costs. We create values for our customers, shareholders and employees.

The company has currently 20 rapid diagnostic tests within the portfolio addressing various healthcare needs (family planning, preventive healthcare, allergies, infectious diseases, and point of care).

Products intended for home-use

OvuQuick250

 

 

 

OvuQUICK

GraviQUICK

 

GlutenCHECK

CholesterinCHECK

FertiQuick

 

 

 

 

 

 

 

FertiQUICK

VagiQUICK

 

 

 

VagiQUICK

MenoQUICK

GraviQUICK Frühtest

FOBCHECK

Heli C CHECK

 

 

 

 

Heli-C-CHECK

AlkoholTEST

MilkCHECK

AllergoCHECK

EierCHECK

Food Supplements Alphabiol Fertility, Alphabiol Pregnancy, Alphabiol Hair Plus, Alphabiol Skin & Hair, Alphabiol Cranberry, Alphabiol Menopause

 

B2B Products:

HIV-QUICK

Troponin I Test, Strep A-Test, Influenza A/B Test, Albumin Dipstick-Tube Test, D-Dimer Test

Philosophy and Vision

NanoRepro AG aims to provide the modern innovative rapid diagnostic tests of high-quality for the preventive health-care of every person. We belong to the leading German manufacturers in the sector of self-diagnostics.

In today's world there is an increasing interest in rapid diagnostic tests, and so the demand for such products is growing continuously. The steady raise of this medical market segment is expected in the future.

NanoRepro´s strong and experienced management and partner team ensures innovation strength, product quality and delivery security. Our employees are professionally trained in their field and thus, contribute to the success of the company. In order to meet the high quality requirements, our scientists are working closely with the institutions such as Philipps University of Marburg and Technical University of Munich. In terms of production, the company has a strong and exclusive strategic partnership with a highly experienced German manufacturer specialized in the field of rapid diagnostic tests. With regard to product design and marketing, we ensure maximum flexibility and short time to market. One of our key success factors is the continuous optimization of production costs.

NanoRepro AG is a highly interesting trade partner in regard to the possibility for the exclusive right of sales agreement.

NanoRepro AG aims to create an ever-growing value for its customers, shareholders and employees.

 

Management Board
Lisa Jüngst, CEO

Lisa Jüngst has been within works at NanoRepro AG since 2006. In April 2013, she was elected to the Board of Directors, and prior to that she had been responsible for the marketing, finance and personnel department as well as investor relations. In 2006, Lisa Jüngst was the first employee of the company, and so she brought the first rapid test of NanoRepro AG to market.

Lisa Jüngst studied business management at the University of Fulda. In 2006 she successfully graduated from the university with a degree in business administration. In addition, Lisa Jüngst is a member of the Young Entrepreneurs Alliance.

Please contact us, if you have any questions

NanoRepro AG
Untergasse 8
35037 Marburg
Tel.: +49 (0)6421 – 95 14 49
Fax: +49 (0)6421 – 95 14 51
E-Mail:
This email address is being protected from spambots. You need JavaScript enabled to view it.
www.nano.ag

OTC News

June 29 2016 The NHS should support clinical pharmacist roles in community pharmacies as well as at GP practices, the New NHS Alliance has proposed.
December 7 2015 Pharmacists in Scotland have been asked to share their views on what politicians need to be made aware of ahead of the Scottish Parliament elections in 2016. The Royal Pharmaceutical Society...